CORT
Corcept Therapeutics Inc
Price:  
33.34 
USD
Volume:  
941,859.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

CORT WACC - Weighted Average Cost of Capital

The WACC of Corcept Therapeutics Inc (CORT) is 6.8%.

The Cost of Equity of Corcept Therapeutics Inc (CORT) is 9.40%.
The Cost of Debt of Corcept Therapeutics Inc (CORT) is 5.00%.

Range Selected
Cost of equity 8.30% - 10.50% 9.40%
Tax rate 14.00% - 16.60% 15.30%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.3% - 7.3% 6.8%
WACC

CORT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.95 1
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.30% 10.50%
Tax rate 14.00% 16.60%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.3% 7.3%
Selected WACC 6.8%